Metformin is usually the first tablet for type 2 diabetes, but it is rarely the last. The classes added after it - sulfonylureas, SGLT2 inhibitors, DPP-4 inhibitors, and the injectable GLP-1 agonists - differ less in how much they lower blood sugar than in what else they do: effects on weight, on the heart and kidneys, on the risk of low blood sugar, and on what they ask of you day to day. Needing a second or third is expected rather than a failure.
Which you are offered depends on your kidney function, your heart history, your weight and what you can tolerate. Follow the plan you were given.
Sulfonylureas
Gliclazide and glimepiride push the pancreas to release more insulin. They work quickly and are inexpensive, which keeps them in use.
Two things follow from the mechanism. They can cause hypoglycaemia - low blood sugar - because they increase insulin regardless of what your blood sugar is doing. Learn the symptoms: shaking, sweating, confusion, hunger, irritability. Know how to treat it, keep something sugary with you, and be careful with driving, missed meals and alcohol, which our guide to medicines and alcohol covers - alcohol can cause delayed lows hours afterwards.
They also tend to cause modest weight gain. If you drive, DVLA rules apply to medicines that can cause hypoglycaemia; ask your diabetes team what you need to do.
SGLT2 inhibitors
Dapagliflozin, empagliflozin and similar drugs make the kidneys excrete glucose in the urine. They lower blood sugar without driving insulin, so they rarely cause hypoglycaemia alone, and they tend to reduce weight and blood pressure slightly.
Their bigger story is outside diabetes: trials have shown benefits for heart failure and for chronic kidney disease, and they are now prescribed for those reasons in people without diabetes at all. If you have been given one and also have heart or kidney disease, that is likely part of the thinking.
Things to know: genital thrush and urinary infections are more common, because there is sugar in the urine - genital hygiene helps, and it is treatable. They can cause dehydration, so sick day rules matter - these are usually paused during illness with vomiting, diarrhoea or fever. And there is a rare risk of diabetic ketoacidosis, which can occur even with near-normal blood sugar. Seek urgent help for nausea and vomiting, abdominal pain, deep or rapid breathing, or a fruity smell on the breath. Tell any surgical team you take one.
DPP-4 inhibitors
Sitagliptin, linagliptin and others increase the body's own incretin hormones, which stimulate insulin after eating. They are generally well tolerated, weight-neutral, and unlikely to cause hypoglycaemia on their own.
Their blood sugar effect is modest compared with some alternatives, and they do not carry the cardiovascular and kidney benefits shown for SGLT2 inhibitors and GLP-1 agonists. They are often chosen where tolerability matters most. Rarely they cause pancreatitis - severe persistent abdominal pain radiating to the back needs urgent assessment.
GLP-1 agonists
Mostly injectable, though an oral form exists. They slow stomach emptying, increase insulin after meals and reduce appetite, producing substantial weight loss in many people alongside blood sugar control, with cardiovascular benefit demonstrated for several.
Nausea is common early and usually settles as the dose is built up gradually. As with DPP-4 inhibitors, pancreatitis is a rare but important risk.
These are also licensed for weight management under different brand names, which has driven heavy demand and a substantial trade in falsified product. Only ever obtain them through a regulated pharmacy - our guide to checking an online pharmacy explains what to look for, and the counterfeit versions of these specifically have caused hospital admissions.
Pioglitazone and insulin
Pioglitazone improves insulin sensitivity and is still used in some situations, though fluid retention, weight gain and fracture risk limit it.
Insulin is used in type 2 diabetes when tablets are no longer enough. Needing it is not a punishment or a personal failure - type 2 diabetes is progressive, and the pancreas produces less over time.
Monitoring and reviews
Whatever you take, expect regular HbA1c checks, kidney function tests, blood pressure, cholesterol, annual eye screening and annual foot checks. Our guide to monitoring long-term medicines covers why these matter.
Ask your team which of your medicines are on your sick day rules list, whether your combination carries a hypoglycaemia risk, and what the plan is if the current one stops being enough. Knowing the answer in advance makes an illness or a change far less alarming.
If this was useful, Insulin: What to Expect When You Start is worth reading next, and Medicines collects the rest.